Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Recombinant human C1-inhibitor

EU orphan designation number: EU/3/07/435   
Active ingredient: Recombinant human C1-inhibitor
Indication: Prevention of delayed graft function after solid organ transplantation
Sponsor: Pharming Group N.V.
Darwinweg 24, NL-2333 CR Leiden, Nederland

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
22/02/2007 Centralised Orphan - Designation EMEA/OD/086/06 (2007)600 of 20/02/2007
22/06/2009 Other procedure